THURSDAY, AUGUST 22nd 2019
Jyrki Heino, Biocity Turku
Jukka Kola, Rector, University of Turku
Presentation of the Elias Tillandz prize for the best publication in BioCity Turku 2018
SESSION I – Early life, education of immune system (chair: Riitta Lahesmaa)
Petter Brodin, Karolinska Institutet, Stockholm, Sweden: Immune system development in early childhood.
Roser Vento-Tormo, Sanger Institute, UK: Reconstructing the maternal-fetal interference during early pregnancy.
POSTER SESSION A and coffee/tea with exhibition
Kathy McCoy, University of Calgary, Canada: Microbiome, Metabolites and Immune Responses.
Ubaid Ullah, University of Turku: Early signs of Type 1 Diabetes
Matej Oresic, University of Turku: Prenatal Exposure to environmental chemicals modulates serum phospholipids in newborns, increasing the risk of type 1 diabetes
Lunch and exhibition
SESSION II – Host metabolism and inflammation, metabolic disorders (Chair: Pirjo Nuutila)
Francesc Villarroya, University of Barcelona, Spain: Cross-talk of immune cells and brown adipocytes in the control of adaptive energy metabolism.
Gökhan S. Hotamışlıgil, Harvard University TH Chan School of Public Health, Boston, USA: Foundations of immunometabolism and implications for metabolic health and disease.
Marja Heiskanen, Turku PET centre: Short-term exercise training decreases pancreatic fat content regardless of baseline glucose tolerance
Eleni Rebelos: Turku PET Centre: Is there central inflammation in obese humans? The BARIBRAIN study
End of first symposium day
Symposium dinner in Turku Castle
FRIDAY, AUGUST 23rd 2019
SESSION III – Neuro-immunology, microglia and neurodegenerative diseases (Chair: Juha Rinne and Laura Airas)
David Pitt, Yale School of Medicine, New Haven, USA: Astrocytes as mediators of inflammation in multiple sclerosis.
Anna Orr, Weill Cornell Medicine, New York, USA: Glial Cells and Neuroimmune Signaling in Cognitive Deficits.
POSTER SESSION B and coffee/tea with exhibition
Bengt Winblad, Karolinska Institutet, Stockholm, Sweden: Immunological treatment in Alzheimer’s disease.
Marcus Sucksdorff, Turku University Hospital: Natalizumab treatment reduces microglial activation in multiple sclerosis
Lunch and exhibition
SESSION IV – Onco-immunology to cure cancer (chair: Sirpa Jalkanen)
Arlene Sharpe, Harvard Medical School, Boston, USA: The biology behind PD-1 checkpoint blockade.
Tyler Curiel, UTHSCSA, Medicine, San Antonio, USA: Age effects on cancer immunotherapy.
Maija Hollmén, University of Turku: Converting cold tumors hot – a Clever approach
Jukka Westermarck, University of Turku: Tumor Suppressor PP2A in Cancer Initiation and Therapy
Jyrki Heino, University of Turku, Closing remarks